|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Genentech Pours $95M Into Constellation’s Drug Platform
|
Arlene Weintraub |
01/17/12 |
Boston
|
|
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News
|
Erin Kutz |
09/16/11 |
Boston
|
|
Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A
|
Erin Kutz |
09/12/11 |
Boston
|
|
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial
|
Arlene Weintraub |
09/06/11 |
Boston
|
|
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment
|
Arlene Weintraub |
07/05/11 |
Boston
|
|
Constellation Pharma Raises More Money and Further Defines Pipeline
|
Arlene Weintraub |
06/17/11 |
Boston
|
|
Constellation Pharma Raises $15M for Epigenetic Drugs
|
Gregory T. Huang |
06/06/11 |
Boston
|
|
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai
|
Ryan McBride |
03/10/11 |
Boston
|
|
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients
|
Ryan McBride |
12/10/10 |
Boston
|
|
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D
|
Luke Timmerman |
10/05/10 |
Boston
|
|
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/11/10 |
Boston
|
|
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer
|
Ryan McBride |
06/08/10 |
Boston
|
|
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/04/10 |
Boston
|
|
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma
|
Ryan McBride |
06/02/10 |
Boston
|
|
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO
|
Ryan McBride |
03/24/10 |
Boston
|
|
New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research
|
Ryan McBride |
09/01/09 |
Boston
|
|
Constellation Pharma Hires New CEO, Collects Last $17M of its Series A Financing
|
Ryan McBride |
08/13/09 |
Boston
|
|
Epizyme Unveils Technology, Targeting Cancer with Epigenetic Drugs
|
Ryan McBride |
04/20/09 |
Boston
|
|
With Backing From MPM and Kleiner Perkins, EpiZyme Aims to Turn Genes On and Off
|
Luke Timmerman |
09/26/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
